Patented Fibromyalgia Treatment Device - Medical Innovation

This listing presents a unique opportunity to acquire a patented, first-of-its-kind medical device designed to treat fibromyalgia symptoms without the use of medication. Developed by a client with 7 existing patents, this device offers a non-pharmacological solution for a chronic condition affecting millions worldwide (250 million globally, 10 million in the US, 12 million in the EU). The device has demonstrated effectiveness in reversing symptoms for 3-6 months after a 30-day treatment period, with no known side effects, and can be reused as symptoms return. Sold directly to consumers through online channels, the business has generated $15,199 in sales with a cash flow of $4,149. While facilities are listed as N/A and real estate is not included, the business boasts no direct competition with equivalent services and significant growth potential due to the vast number of potential customers. The seller is motivated by other business interests and is open to negotiating transition support. An NDA is required to access the executive summary.